Enlivex Therapeutics Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.9360
-0.0016 (-0.17%)
May 30, 2025, 4:00 PM - Market closed
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of $22.32 million as of June 2, 2025. Its market cap has decreased by -17.32% in one year.
Market Cap
22.32M
Enterprise Value
1.77M
1-Year Change
-17.32%
Ranking
Category
Stock Price
$0.94
Market Cap Chart
Since July 31, 2014, Enlivex Therapeutics's market cap has decreased from $92.70M to $22.32M, a decrease of -75.92%. That is a compound annual growth rate of -12.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 22.30M | -13.23% |
| Dec 31, 2024 | 25.70M | -48.80% |
| Dec 29, 2023 | 50.20M | -30.76% |
| Dec 30, 2022 | 72.50M | -36.74% |
| Dec 31, 2021 | 114.60M | 31.57% |
| Dec 31, 2020 | 87.10M | 2,388.57% |
| Dec 31, 2019 | 3.50M | 34.62% |
| Dec 31, 2018 | 2.60M | -65.33% |
| Dec 29, 2017 | 7.50M | -49.32% |
| Dec 30, 2016 | 14.80M | -73.14% |
| Dec 31, 2015 | 55.10M | -33.69% |
| Dec 31, 2014 | 83.10M | -10.36% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |